All news
Politics
Business
Technology
Incidents
Sports
Weather
Science
Entertainment
World
Real Estate
AI News
GLP-1 based medication shows ability to delay aging in micePhoto by Haberdoedas Photography on Pexels
Science
Медицина

GLP-1 based medication shows ability to delay aging in mice

Público2 September 2026 at 19:30

A study conducted with mice demonstrated that a GLP-1 based medication, semaglutide, was able to delay the aging process in the animals. The mice that received the medication at an advanced age showed an increase in life expectancy compared to the control group.

In addition to the increase in longevity, the mice treated with semaglutide showed significant improvements in various areas. Improvements were observed in the physical, metabolic, and cognitive functions of the animals that received the medication.

The study suggests that semaglutide, originally developed for the treatment of diabetes and obesity, may have beneficial effects that go beyond weight control and glycemic control, potentially interfering with the fundamental mechanisms of cellular aging.

Related articles

UMinho: Rui L. Reis reconduzido na presidência do I3BsPhoto by Ivett M on Pexels
Science

UMinho: Rui L. Reis reconducted as president of I3Bs

Full Professor Rui L. Reis was reconducted as president of I3Bs – Institute of Research on Biomaterials, Biodegradables and Biomimetics of the University of Minho, in a decision made on Wednesday, September 2. This reconduction ensures the continuity of the researcher's leadership at the head of one of the main research centers of UMinho in the field of biomaterials and biomimetics.

Guimarães, agora!02/09/26, 21:00
Cientistas descobrem possível benefício inesperado envolvendo semaglutida e saúde mentalPhoto by Helder Sato on Pexels
Science

Scientists discover possible unexpected benefit involving semaglutide and mental health

A study conducted with nearly 15,000 people in Sweden found an association between the use of semaglutide — the active compound in medications like Ozempic and Wegovy — and a lower risk of psychiatric hospitalization among patients with bipolar disorder. The research, conducted by Griffith University, pointed to a 21% reduction in hospitalization risk, but scientists warn that the result does not prove that the medication is responsible for the improvement. The discovery suggests that GLP-1 receptor agonists (GLP-1 RAs) may influence the brain, in addition to blood sugar levels and appetite.

extra02/09/26, 20:35
La 'era Ozempic' no mata las dietas: septiembre dispara hasta un 40% las consultas para perder peso
Science

The 'Ozempic era' hasn't killed diets: September sees up to 40% spike in weight loss consultations

In September, with the return to routines after summer, interest in losing weight surges, with an increase of up to 40% in nutrition consultations. Despite the popularization of weight-loss medications from the "Ozempic era," nutritionists continue to note significant demand for popular diets and healthier eating habits among patients who return with the goal of shedding the pounds gained during summer vacation.

El Periódico Mediterráneo - General02/09/26, 20:10
Os níveis de testosterona podem diminuir com a idade: 7 hábitos que um urologista recomenda para cuidar delaPhoto by Guto Macedo on Pexels
Science

Testosterone levels can decrease with age: 7 habits a urologist recommends to take care of it

The article addresses the natural decrease in testosterone levels with male aging and presents seven habits recommended by urologist Guillermo Romero to maintain hormonal health, including physical exercise, weight control, proper nutrition, rest and stress management, as alternatives to drug treatments.

oglobo02/09/26, 19:57